<DOC>
	<DOCNO>NCT01086878</DOCNO>
	<brief_summary>The purpose study determine prophylactic cotrimoxazole make severe anemia neutropenia common infant expose maternal HIV combination antiretroviral therapy .</brief_summary>
	<brief_title>Safety Cotrimoxazole HIV- HAART-exposed Infants</brief_title>
	<detailed_description>Each year , 2 million child bear HIV-infected woman . The World Health Organization ( WHO ) recommend infant receive cotrimoxazole ( CTX ) prophylaxis start 4-6 week age period infant HIV transmission risk , infant know HIV-uninfected . There also increase interest study CTX prophylaxis give infant HIV-infected woman time initiation replacement feeding , regardless infant HIV infection status , mitigate high risk infant morbidity mortality associate formula feed develop world . However , infant utero exposure maternal antiretroviral drug lead hematologic toxicity infant . It critical know whether infant CTX prophylaxis exacerbate hematologic toxicity associate perinatal ARV exposure . This question , broad public health implication , never study . We study hematologic toxicity associate CTX prophylaxis give infant expose maternal HAART Botswana . We use exist data large cohort receive CTX , enroll small cohort receive CTX accord Botswana national guideline .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Both maternal infant criterion need meet : Maternal document HIV infection take 3drug highly active antiretroviral therapy point pregnancy ( note : include 2 NRTI+NNRTI , 2NRTI+PI , 3 NRTI ) 21 year age old , able willing sign inform consent Proof Botswana Citizenship Maternal involuntary incarceration Infant young 42 day age able bring regular visit study clinic least 6 month postpartum Infant know preexist birth anomaly result high probability baby survive 6 month know hypersensitivity cotrimoxazole</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Antiretroviral Therapy , Highly Active</keyword>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>anemia</keyword>
	<keyword>neutropenia</keyword>
	<keyword>safety</keyword>
	<keyword>hematologic toxicity</keyword>
</DOC>